BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 30575141)

  • 1. Senescent fibroblasts in melasma pathophysiology.
    Kim M; Kim SM; Kwon S; Park TJ; Kang HY
    Exp Dermatol; 2019 Jun; 28(6):719-722. PubMed ID: 30575141
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Senescent fibroblasts drive ageing pigmentation: ​A potential therapeutic target for senile lentigo.
    Yoon JE; Kim Y; Kwon S; Kim M; Kim YH; Kim JH; Park TJ; Kang HY
    Theranostics; 2018; 8(17):4620-4632. PubMed ID: 30279727
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Clinical and Biochemical Evaluation of a Temperature-Controlled Continuous Non-Invasive Radiofrequency Device for the Treatment of Melasma.
    Kwon SH; Na JI; Huh CH; Park KC
    Ann Dermatol; 2021 Dec; 33(6):522-530. PubMed ID: 34858003
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of fibroblast-derived factors in the pathogenesis of melasma.
    Byun JW; Park IS; Choi GS; Shin J
    Clin Exp Dermatol; 2016 Aug; 41(6):601-9. PubMed ID: 27416970
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histopathological comparison of lesional and perilesional skin in melasma: A cross-sectional analysis.
    Gautam M; Patil S; Nadkarni N; Sandhu M; Godse K; Setia M
    Indian J Dermatol Venereol Leprol; 2019; 85(4):367-373. PubMed ID: 30516167
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Senescent Fibroblast-Derived GDF15 Induces Skin Pigmentation.
    Kim Y; Kang B; Kim JC; Park TJ; Kang HY
    J Invest Dermatol; 2020 Dec; 140(12):2478-2486.e4. PubMed ID: 32416083
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The vascular characteristics of melasma.
    Kim EH; Kim YC; Lee ES; Kang HY
    J Dermatol Sci; 2007 May; 46(2):111-6. PubMed ID: 17363223
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased expression of TGF-β protein in the lesional skins of melasma patients following treatment with platelet-rich plasma.
    Hofny ERM; Hussein MRA; Ghazally A; Ahmed AM; Abdel-Motaleb AA
    J Cosmet Laser Ther; 2019; 21(7-8):382-389. PubMed ID: 31554441
    [No Abstract]   [Full Text] [Related]  

  • 9. Premature cell senescence in human skin: Dual face in chronic acquired pigmentary disorders.
    Bellei B; Picardo M
    Ageing Res Rev; 2020 Jan; 57():100981. PubMed ID: 31733332
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Melasma: histopathological characteristics in 56 Korean patients.
    Kang WH; Yoon KH; Lee ES; Kim J; Lee KB; Yim H; Sohn S; Im S
    Br J Dermatol; 2002 Feb; 146(2):228-37. PubMed ID: 11903232
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Melasma: Updates and perspectives.
    Kwon SH; Na JI; Choi JY; Park KC
    Exp Dermatol; 2019 Jun; 28(6):704-708. PubMed ID: 30422338
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD4, IL-17, and COX-2 Are Associated With Subclinical Inflammation in Malar Melasma.
    Rodríguez-Arámbula A; Torres-Álvarez B; Cortés-García D; Fuentes-Ahumada C; Castanedo-Cázares JP
    Am J Dermatopathol; 2015 Oct; 37(10):761-6. PubMed ID: 26381025
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Solar elastosis and presence of mast cells as key features in the pathogenesis of melasma.
    Hernández-Barrera R; Torres-Alvarez B; Castanedo-Cazares JP; Oros-Ovalle C; Moncada B
    Clin Exp Dermatol; 2008 May; 33(3):305-8. PubMed ID: 18419607
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Arginase-2, a miR-1299 target, enhances pigmentation in melasma by reducing melanosome degradation via senescence-induced autophagy inhibition.
    Kim NH; Choi SH; Yi N; Lee TR; Lee AY
    Pigment Cell Melanoma Res; 2017 Jan; 30(6):521-530. PubMed ID: 28627081
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo multiphoton microscopy of melasma.
    Lentsch G; Balu M; Williams J; Lee S; Harris RM; König K; Ganesan A; Tromberg BJ; Nair N; Santhanam U; Misra M
    Pigment Cell Melanoma Res; 2019 May; 32(3):403-411. PubMed ID: 30506627
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Q-switched Nd: YAG laser alone or with modified Jessner chemical peeling for treatment of mixed melasma in dark skin types: A comparative clinical, histopathological, and immunohistochemical study.
    Saleh F; Moftah NH; Abdel-Azim E; Gharieb MG
    J Cosmet Dermatol; 2018 Jun; 17(3):319-327. PubMed ID: 29057567
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo reflectance confocal microscopy detects pigmentary changes in melasma at a cellular level resolution.
    Kang HY; Bahadoran P; Suzuki I; Zugaj D; Khemis A; Passeron T; Andres P; Ortonne JP
    Exp Dermatol; 2010 Aug; 19(8):e228-33. PubMed ID: 20497220
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The dermal stem cell factor and c-kit are overexpressed in melasma.
    Kang HY; Hwang JS; Lee JY; Ahn JH; Kim JY; Lee ES; Kang WH
    Br J Dermatol; 2006 Jun; 154(6):1094-9. PubMed ID: 16704639
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A study of efficacy and safety of high-intensity focused ultrasound for the treatment of melasma in Asians: A single-blinded, randomized, split-face, pilot study.
    Vachiramon V; Iamsumang W; Chanasumon N; Thadanipon K; Triyangkulsri K
    J Cosmet Dermatol; 2020 Feb; 19(2):375-381. PubMed ID: 31173464
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Skin-Aging Pigmentation: Who Is the Real Enemy?
    Kim JC; Park TJ; Kang HY
    Cells; 2022 Aug; 11(16):. PubMed ID: 36010618
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.